Dr. Jonathan Macy, MD

NPI: 1922020205
Total Payments
$58,109
2024 Payments
$484.80
Companies
23
Transactions
137
Medicare Patients
12,872
Medicare Billing
$1.3M

Payment Breakdown by Category

Research$53,508 (92.1%)
Food & Beverage$4,054 (7.0%)
Other$490.00 (0.8%)
Gifts$38.80 (0.1%)
Travel$18.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $53,508 10 92.1%
Food and Beverage $4,054 122 7.0%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $490.00 2 0.8%
Gift $38.80 2 0.1%
Travel and Lodging $18.00 1 0.0%

Payments by Type

Research
$53,508
10 transactions
General
$4,601
127 transactions

Top Paying Companies

Company Total Records Latest Year
SUN PHARMACEUTICAL INDUSTRIES INC. $41,756 15 $0 (2024)
Valeant Pharmaceuticals North America LLC $11,988 5 $0 (2017)
Alcon Vision LLC $893.08 8 $0 (2024)
Allergan, Inc. $839.83 23 $0 (2022)
Alcon Laboratories Inc $380.91 7 $0 (2018)
Bausch & Lomb, a division of Bausch Health US, LLC $297.96 13 $0 (2021)
ABBVIE INC. $258.87 7 $0 (2024)
Shire North American Group Inc $254.96 6 $0 (2019)
Kala Pharmaceuticals, Inc. $245.19 10 $0 (2022)
Novartis Pharmaceuticals Corporation $212.33 9 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $484.80 14 Alcon Vision LLC ($130.24)
2023 $988.09 14 Alcon Vision LLC ($603.28)
2022 $410.88 16 ABBVIE INC. ($116.98)
2021 $669.17 20 Allergan, Inc. ($385.76)
2020 $41,930 21 Sun Pharmaceutical Industries Inc. ($41,581)
2019 $440.67 15 Bausch & Lomb, a division of Bausch Health US, LLC ($213.82)
2018 $731.37 19 Allergan Inc. ($218.42)
2017 $12,454 18 Valeant Pharmaceuticals North America LLC ($11,988)

All Payment Transactions

137 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
12/06/2024 RxSight Inc RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR HANDPIECE, RXSIGHT INJECTOR CARTRIDGE Food and Beverage In-kind items and services $24.95 General
Category: OPHTHALMOLOGY
11/23/2024 Bausch & Lomb Americas Inc. MIEBO (Drug) Food and Beverage In-kind items and services $19.07 General
Category: Ophthalmology
11/12/2024 ABBVIE INC. LUMIGAN (Drug) Food and Beverage In-kind items and services $25.69 General
Category: EYE CARE
11/06/2024 Tarsus Pharmaceuticals, Inc. XDEMVY (Drug) Food and Beverage In-kind items and services $33.05 General
Category: DEMODEX BLEPHARITIS
09/11/2024 SUN PHARMACEUTICAL INDUSTRIES INC. Cequa (Drug) Food and Beverage In-kind items and services $36.14 General
Category: Ophthalmology
09/03/2024 Tarsus Pharmaceuticals, Inc. XDEMVY (Drug) Food and Beverage In-kind items and services $41.95 General
Category: DEMODEX BLEPHARITIS
08/13/2024 Alcon Vision LLC Constellation (Device) Food and Beverage In-kind items and services $130.24 General
Category: Ophthalmology
07/08/2024 BIOTISSUE HOLDINGS INC. Food and Beverage Cash or cash equivalent $20.87 General
06/20/2024 Bausch & Lomb Americas Inc. enVista MX60 IOL (Device) Food and Beverage In-kind items and services $18.88 General
Category: Ophthalmology
05/24/2024 Sight Sciences, Inc. TEARCARE SYSTEM (Device) Food and Beverage In-kind items and services $14.45 General
Category: Ophthalmology
05/03/2024 Tarsus Pharmaceuticals, Inc. XDEMVY (Drug) Food and Beverage In-kind items and services $38.72 General
Category: DEMODEX BLEPHARITIS
04/04/2024 Johnson & Johnson Surgical Vision, Inc. Tecnis Simplicity (Device) Food and Beverage In-kind items and services $34.78 General
Category: Optics
01/05/2024 Dompe US, Inc. OXERVATE (Drug) Food and Beverage In-kind items and services $28.29 General
Category: SOLUTION/ DROPS
01/02/2024 Bausch & Lomb Americas Inc. XIIDRA (Drug) Food and Beverage In-kind items and services $17.72 General
Category: Ophthalmology
12/06/2023 Sun Pharmaceutical Industries Inc. Cequa (Drug) Food and Beverage In-kind items and services $27.16 General
Category: Ophthalmology
11/13/2023 Horizon Therapeutics plc TEPEZZA (Drug) Food and Beverage In-kind items and services $24.34 General
Category: TEPEZZA
10/26/2023 ABBVIE INC. XEN GLAUCOMA TREATMENT SYSTEM (Device) Food and Beverage In-kind items and services $99.86 General
Category: EYE CARE
08/23/2023 Bausch & Lomb Americas Inc. IC-8 Apthera IOL (Device) Food and Beverage In-kind items and services $22.62 General
Category: Ophthalmology
08/09/2023 RxSight Inc RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE Food and Beverage In-kind items and services $26.55 General
Category: OPHTHALMOLOGY
07/21/2023 Novartis Pharmaceuticals Corporation XIIDRA (Drug) Food and Beverage In-kind items and services $24.92 General
Category: Ophthalmology
06/29/2023 Alcon Vision LLC Clareon (Device) Food and Beverage In-kind items and services $162.18 General
Category: Ophthalmology
06/26/2023 NEW WORLD MEDICAL,INC. Food and Beverage In-kind items and services $79.94 General
06/23/2023 Novartis Pharmaceuticals Corporation XIIDRA (Drug) Food and Beverage In-kind items and services $34.40 General
Category: Ophthalmology
05/31/2023 Novartis Pharmaceuticals Corporation XIIDRA (Drug) Food and Beverage In-kind items and services $14.05 General
Category: Ophthalmology
04/01/2023 Alcon Vision LLC Food and Beverage In-kind items and services $310.15 General

Research Studies & Clinical Trials

Study Name Company Amount Records
A Phase 3, Multicenter, Randomized, Double-Masked, Parallel-Group, Comparative Study to Evaluate the Clinical Efficacy and Safety of ISV-305 (0.1% Dexamethasone) Compared to Vehicle in the Treatment of Subjects With Blepharitis Sun Pharmaceutical Industries Inc. $41,564 7
A Phase 3, Multi-Center, Double-Masked, Vehicle-Controlled, Randomized, Parallel-Group Study to Assess Loteprednol Etabonate Ophthalmic Gel, 0.38 BID and TID versus Vehicle Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery Valeant Pharmaceuticals North America LLC $11,944 3

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 20 3,493 4,430 $1.8M $357,721
2022 21 3,285 4,163 $1.7M $344,897
2021 23 3,239 4,006 $1.6M $337,493
2020 23 2,855 3,434 $1.2M $279,773
Total Patients
12,872
Total Services
16,033
Medicare Billing
$1.3M
Procedure Codes
87

All Medicare Procedures & Services

87 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
92014 Established patient complete exam of visual system Office 2023 911 1,232 $450,912 $125,656 27.9%
66984 Removal of cataract with insertion of prosthetic lens Facility 2023 92 131 $550,855 $61,482 11.2%
92012 Established patient problem focused exam of visual system Office 2023 380 636 $161,544 $47,669 29.5%
92004 New patient complete exam of visual system Office 2023 264 264 $115,896 $30,134 26.0%
92250 Photography of the retina Office 2023 540 632 $125,768 $19,358 15.4%
66982 Complex removal of cataract with insertion of prosthetic lens Facility 2023 16 18 $88,452 $11,549 13.1%
66821 Removal of recurring cataract in lens capsule using a laser Office 2023 29 36 $36,223 $10,724 29.6%
92134 Imaging of retina Office 2023 211 225 $27,450 $7,620 27.8%
92136 Measurement of corneal curvature and depth of eye Office 2023 131 180 $48,780 $7,161 14.7%
68761 Closure of tear duct opening using plug Office 2023 32 40 $37,378 $7,109 19.0%
92201 Extended exam of the back part of the eye with retinal drawing Office 2023 293 341 $24,893 $6,786 27.3%
92083 Exam of visual field with extended testing Office 2023 104 104 $20,072 $5,665 28.2%
92025 Ct scan of cornea Office 2023 139 191 $21,392 $5,431 25.4%
92060 Exam to measure eye deviation and range of motion Office 2023 54 68 $13,124 $3,652 27.8%
92133 Imaging of optic nerve Office 2023 60 61 $6,771 $1,861 27.5%
92020 Exam of the internal drainage system of eye Office 2023 75 80 $6,320 $1,800 28.5%
68840 Probing of nasal tear duct Office 2023 12 12 $6,443 $1,720 26.7%
92202 Extended exam of the back part of the eye with optic nerve drawing Office 2023 91 105 $4,935 $1,366 27.7%
67820 Removal of eyelashes using forceps Office 2023 21 36 $7,800 $643.84 8.3%
76514 Ultrasound scan of cornea to determine thickness Office 2023 38 38 $1,710 $335.70 19.6%
92014 Established patient complete exam of visual system Office 2022 819 1,132 $414,240 $114,150 27.6%
66984 Removal of cataract with insertion of prosthetic lens Facility 2022 94 127 $534,035 $59,982 11.2%
92012 Established patient problem focused exam of visual system Office 2022 346 627 $159,258 $46,708 29.3%
92004 New patient complete exam of visual system Office 2022 264 264 $115,896 $29,226 25.2%
66982 Complex removal of cataract with insertion of prosthetic lens Facility 2022 30 35 $171,990 $22,652 13.2%

About Dr. Jonathan Macy, MD

Dr. Jonathan Macy, MD is a Ophthalmology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922020205.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Macy, MD has received a total of $58,109 in payments from pharmaceutical and medical device companies, with $484.80 received in 2024. These payments were reported across 137 transactions from 23 companies. The most common payment nature is "" ($53,508).

As a Medicare-enrolled provider, Macy has provided services to 12,872 Medicare beneficiaries, totaling 16,033 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.

Practice Information

  • Specialty Ophthalmology
  • Location Los Angeles, CA
  • Active Since 07/24/2006
  • Last Updated 02/14/2020
  • Taxonomy Code 207W00000X
  • Entity Type Individual
  • NPI Number 1922020205

Products in Payments

  • LOTEMAX GEL (Drug) $11,944
  • XIIDRA (Drug) $289.73
  • LUMIGAN (Drug) $266.09
  • INVELTYS (Drug) $245.19
  • Constellation (Device) $241.93
  • Clareon (Device) $162.18
  • PROLENSA (Drug) $160.12
  • RESTASIS (Drug) $158.10
  • STELLARIS PC (Device) $149.47
  • HYDRUS Microstent (Device) $130.95
  • DURYSTA (Drug) $124.84
  • ORA (Device) $120.03
  • Tecnis 1-piece IOL (Device) $116.19
  • OXERVATE (Drug) $114.51
  • XDEMVY (Drug) $113.72
  • XEN GLAUCOMA TREATMENT SYSTEM (Device) $99.86
  • Cequa (Drug) $87.32
  • RESTASIS MULTIDOSE (Drug) $67.80
  • TEPEZZA (Drug) $58.67
  • RXSIGHT CONTACT LENS (Device) $51.50

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Ophthalmology Doctors in Los Angeles